Vericel Corp Ord (VCEL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.91B
Last updated: Nov 17, 2026 at 11:05 AM ET
Vericel Corp Ord (VCEL) Competitors
The companies most similar to Vericel Corp Ord are Vera Therapeutics (VERA), Viridian Therapeutics (VRDN) and Vir Biotechnology (VIR). By market cap, Vericel Corp Ord ranks 7th of the 13 companies on this page; Viking Therapeutics (VKTX) is the largest at $3.73B.
Peer Comparison
VCEL's revenue growth of 26.5% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Vericel Corp Ord (VCEL) | $2.91B | 89.8x | 9.1x | 10.3% | N/A | 26.5% | 0.00% |
| Vera Therapeutics Inc (VERA) | $2.03B | N/A | 189.3x | 0.0% | -83.0% | 0.0% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Xencor Inc (XNCR) | $2.78B | N/A | 13.5x | -58.8% | -17.3% | 454.9% | 0.00% |
| Celcuity LLC (CELC) | $3.15B | N/A | N/A | 0.0% | -25.2% | 0.0% | 0.00% |
| Pharvaris BV (PHVS) | $2.36B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Celldex Therapeutics Inc (CLDX) | $2.26B | N/A | N/A | 0.0% | N/A | -97.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Iovance Biotherapeutics Inc (IOVA) | $3.59B | N/A | 9.1x | -58.2% | N/A | 80.1% | 0.00% |
| Viking Therapeutics Inc (VKTX) | $3.73B | N/A | N/A | 0.0% | -61.0% | 0.0% | 0.00% |
| Enliven Therapeutics Inc. (ELVN) | $3.59B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $2.97B | 266.5x | 13.5x | 0.0% | -35.7% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Vericel Corp Ord, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Vera Therapeutics Inc (VERA) | Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases... | VERA competitors |
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Xencor Inc (XNCR) | Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed... | XNCR competitors |
| Celcuity LLC (CELC) | Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States. | CELC competitors |
| Pharvaris BV (PHVS) | Pharvaris NV, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. | PHVS competitors |
| Celldex Therapeutics Inc (CLDX) | Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment... | CLDX competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Iovance Biotherapeutics Inc (IOVA) | Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness... | IOVA competitors |
| Viking Therapeutics Inc (VKTX) | Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. | VKTX competitors |
| Enliven Therapeutics Inc. (ELVN) | Enliven Therapeutics Inc. (Ticker: ELVN) is an innovative biotechnology company focused on transforming cancer therapies and addressing critical healthcare... | ELVN competitors |
Frequently Asked Questions About VCEL
Who are Vericel Corp Ord's main competitors?
The companies most similar to Vericel Corp Ord include Vera Therapeutics (VERA), Viridian Therapeutics (VRDN), Vir Biotechnology (VIR), Legend Biotech (LEGN) and Xencor (XNCR), listed from the closest match.
Who is Vericel Corp Ord's biggest competitor?
Viking Therapeutics (VKTX) is the largest of the similar companies at $3.73B; Vera Therapeutics (VERA) is the closest match by business profile, size, sector and industry.
How does VCEL stock compare with its competitors?
VCEL's P/E is 89.8x against a peer median of 266.5x; its P/S is 9.1x against a peer median of 13.5x; its net margin is 10.3% against a peer median of 0.0%.
Which of Vericel Corp Ord's competitors pays a higher dividend?
Vericel Corp Ord pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Vericel Corp Ord bigger than its competitors?
No. Vericel Corp Ord is 7th by market cap among the 13 companies on this page; the largest is Viking Therapeutics (VKTX) at $3.73B.
VCEL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors